KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Assets (2016 - 2025)

Historic Return on Assets for Arbutus Biopharma (ABUS) over the last 16 years, with Q3 2025 value amounting to 0.42%.

  • Arbutus Biopharma's Return on Assets rose 900.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.51% for FY2024, which is 800.0% down from last year.
  • According to the latest figures from Q3 2025, Arbutus Biopharma's Return on Assets is 0.42%, which was up 900.0% from 0.49% recorded in Q2 2025.
  • Arbutus Biopharma's Return on Assets' 5-year high stood at 0.31% during Q2 2022, with a 5-year trough of 0.62% in Q1 2025.
  • In the last 5 years, Arbutus Biopharma's Return on Assets had a median value of 0.47% in 2021 and averaged 0.44%.
  • Per our database at Business Quant, Arbutus Biopharma's Return on Assets surged by 9200bps in 2021 and then crashed by -1400bps in 2024.
  • Quarter analysis of 5 years shows Arbutus Biopharma's Return on Assets stood at 0.41% in 2021, then rose by 16bps to 0.35% in 2022, then plummeted by -38bps to 0.48% in 2023, then dropped by -7bps to 0.51% in 2024, then increased by 18bps to 0.42% in 2025.
  • Its Return on Assets was 0.42% in Q3 2025, compared to 0.49% in Q2 2025 and 0.62% in Q1 2025.